Wolfe, A. L. et al. RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer. Nature 513, 65–70 (2014).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Truitt, M. L. et al. Differential requirements for eIF4E dose in normal development and cancer. Cell 162, 59–71 (2015).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kovalski, J. R., Kuzuoglu-Ozturk, D. & Ruggero, D. Protein synthesis control in cancer: selectivity and therapeutic targeting. EMBO J. 41, e109823 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Murphy, D. J. et al. Distinct thresholds govern Myc’s biological output in vivo. Cancer Cell 14, 447–457 (2008).

Article  CAS  PubMed  Google Scholar 

Sodir, N. M. et al. Reversible Myc hypomorphism identifies a key Myc-dependency in early cancer evolution. Nat. Commun. 13, 6782 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sun, X.-X., Li, Y., Sears, R. C. & Dai, M.-S. Targeting the MYC ubiquitination-proteasome degradation pathway for cancer therapy. Front. Oncol. 11, 679445 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pereira, B., Billaud, M. & Almeida, R. RNA-binding proteins in cancer: old players and new actors. Trends Cancer 3, 506–528 (2017).

Article  CAS  PubMed  Google Scholar 

Ray, P. S. et al. A stress-responsive RNA switch regulates VEGFA expression. Nature 457, 915–919 (2009).

Article  CAS  PubMed  Google Scholar 

Dang, C. V. MYC on the path to cancer. Cell 149, 22–35 (2012).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Boike, L. et al. Discovery of a functional covalent ligand targeting an intrinsically disordered cysteine within MYC. Cell Chem. Biol. 28, 4–13 (2021).

Article  CAS  PubMed  Google Scholar 

Whitfield, J. R. & Soucek, L. The long journey to bring a Myc inhibitor to the clinic. J. Cell Biol. 220, e202103090 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Siegel, R. L., Giaquinto, A. N. & Jemal, A. Cancer statistics, 2024. CA Cancer J. Clin. 74, 12–49 (2024).

Article  PubMed  Google Scholar 

Hessmann, E., Schneider, G., Ellenrieder, V. & Siveke, J. T. MYC in pancreatic cancer: novel mechanistic insights and their translation into therapeutic strategies. Oncogene 35, 1609–1618 (2016).

Article  CAS  PubMed  Google Scholar 

Farrell, A. S. et al. MYC regulates ductal-neuroendocrine lineage plasticity in pancreatic ductal adenocarcinoma associated with poor outcome and chemoresistance. Nat. Commun. 8, 1728 (2017).

Article  PubMed  PubMed Central  Google Scholar 

Schneider, G., Wirth, M., Keller, U. & Saur, D. Rationale for MYC imaging and targeting in pancreatic cancer. EJNMMI Res. 11, 104 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Allen-Petersen, B. L. et al. Activation of PP2A and inhibition of mTOR synergistically reduce MYC signaling and decrease tumor growth in pancreatic ductal adenocarcinoma. Cancer Res. 79, 209–219 (2019).

Article  CAS  PubMed  Google Scholar 

Parasido, E. et al. The sustained induction of c-MYC drives nab-paclitaxel resistance in primary pancreatic ductal carcinoma cells. Mol. Cancer Res. 17, 1815–1827 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dilly, J. et al. Mechanisms of resistance to oncogenic kras inhibition in pancreatic cancer. Cancer Discov. 14, 2135–2161 (2024).

Article  PubMed  PubMed Central  Google Scholar 

Evans, J. R. et al. Members of the poly (rC) binding protein family stimulate the activity of the c-myc internal ribosome entry segment in vitro and in vivo. Oncogene 22, 8012–8020 (2003).

Article  PubMed  Google Scholar 

Singh, K. et al. Targeting eIF4A-dependent translation of KRAS signaling molecules. Cancer Res. 81, 2002–2014 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Manjunath, H. et al. Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection. Cell Rep. 29, 3134–3146 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xu, Y. et al. ERα is an RNA-binding protein sustaining tumor cell survival and drug resistance. Cell 184, 5215–5229 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Oksuz, O. et al. Transcription factors interact with RNA to regulate genes. Mol. Cell 83, 2449–2463 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bao, X. et al. Capturing the interactome of newly transcribed RNA. Nat. Methods 15, 213–220 (2018).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hentze, M. W., Castello, A., Schwarzl, T. & Preiss, T. A brave new world of RNA-binding proteins. Nat. Rev. Mol. Cell Biol. 19, 327–341 (2018).

Article  CAS  PubMed  Google Scholar 

Huang, R., Han, M., Meng, L. & Chen, X. Transcriptome-wide discovery of coding and noncoding RNA-binding proteins. Proc. Natl Acad. Sci. USA 115, E3879–E3887 (2018).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Queiroz, R. M. L. et al. Comprehensive identification of RNA–protein interactions in any organism using orthogonal organic phase separation (OOPS). Nat. Biotechnol. 37, 169–178 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Urdaneta, E. C. et al. Purification of cross-linked RNA-protein complexes by phenol-toluol extraction. Nat. Commun. 10, 990 (2019).

Article  PubMed  PubMed Central  Google Scholar 

Luo, E.-C. et al. Large-scale tethered function assays identify factors that regulate mRNA stability and translation. Nat. Struct. Mol. Biol. 27, 989–1000 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guerber, L., Pangou, E. & Sumara, I. Ubiquitin binding protein 2-like (UBAP2L): is it so NICE after all? Front. Cell Dev. Biol. 10, 931115 (2022).

Article  PubMed  PubMed Central